AAOMS Annual Meeting

Only approximately 8% to 10% of stroke patients receive neuroplasticity-based rehabilitation in the optimal treatment setting, according to new data.

Only approximately 8% to 10% of stroke patients receive neuroplasticity-based rehabilitation in the optimal treatment setting, according to new data.

Allen W. Burton, MD, discusses 2 new types of implantable neurostimulation devices featuring 2 advanced spinal column stimulation techniques, which may be superior to conventional tonic spinal cord therapy...

Michael Genovese, MD, JD, chief medical advisor of Acadia Healthcare's Recovery Division, explains how performing a DNA analysis could help physicians select treatment options for depression that are right...

Michael Genovese, MD, JD, chief medical advisor of Acadia Healthcare's Recovery Division, explains how performing a DNA analysis could help physicians select treatment options for depression that are right...

Michael Genovese, MD, JD, chief medical advisor of Acadia Healthcare's Recovery Division, explains how performing a DNA analysis could help physicians select treatment options for depression that are right...

Dr Adam Lipson discusses how closed-loop or "smart" deep brain stimulation systems may help physicians individualize treatment for their patients.

Dr Adam Lipson discusses how closed-loop or "smart" deep brain stimulation systems may help physicians individualize treatment for their patients.

In this video, Sandeep Singh, MD, Vice President of Medical Affairs and Spinal Cord Injury Program Director at Good Shepherd Rehabilitation, discusses the growing use of exoskeletons for rehabilitating...

In this video, Sandeep Singh, MD, Vice President of Medical Affairs and Spinal Cord Injury Program Director at Good Shepherd Rehabilitation, discusses the growing use of exoskeletons for rehabilitating...